BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31047309)

  • 1. Multimodal Imaging of Subhyaloid Hemorrhage in Valsalva Retinopathy Treated with Nd:YAG Laser.
    Vaz-Pereira S; Barata AD
    Ophthalmol Retina; 2018 Jan; 2(1):73. PubMed ID: 31047309
    [No Abstract]   [Full Text] [Related]  

  • 2. Nd:YAG laser hyaloidotomy in the management of Premacular Subhyaloid Hemorrhage.
    Khadka D; Bhandari S; Bajimaya S; Thapa R; Paudyal G; Pradhan E
    BMC Ophthalmol; 2016 Apr; 16():41. PubMed ID: 27090882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal imaging of pre-macular subhyaloid hemorrhage managed with Nd:YAG laser hyaloidotomy.
    Agarwal M; Gupta C; Ranjan R; Kumar B; Shrivastav A; Kumar S
    Indian J Ophthalmol; 2019 Jul; 67(7):1185. PubMed ID: 31238455
    [No Abstract]   [Full Text] [Related]  

  • 4. Spectral-domain optical coherence tomography following Nd:YAG laser membranotomy in valsalva retinopathy.
    Goel N; Kumar V; Seth A; Raina UK; Ghosh B
    Ophthalmic Surg Lasers Imaging; 2011; 42(3):222-8. PubMed ID: 21410093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valsalva retinopathy in pregnancy: SD-OCT features during and after Nd:YAG laser hyaloidotomy.
    Jayaprakasam A; Matthew R; Toma M; Soni M
    Ophthalmic Surg Lasers Imaging; 2011 Feb; 42 Online():e26-8. PubMed ID: 21366206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Valsalva retinopathy.
    Liu Z; Pan X; Bi H
    Optom Vis Sci; 2014 Nov; 91(11):e278-81. PubMed ID: 25279780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nd:YAG membranotomy for sub-inner limiting membrane hemorrhage: a case report.
    Jaime L; Javier L; Nicolás RV; Diego B; Carlos AC
    Rom J Ophthalmol; 2021; 65(1):76-79. PubMed ID: 33817439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Imaging of YAG laser treatment for Valsalva retinopathy].
    Abi-Ayad N; Kodjikian L
    J Fr Ophtalmol; 2011 Jun; 34(6):436-7. PubMed ID: 21459475
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectral-domain OCT evaluation of Nd:YAG laser treatment for Valsalva retinopathy.
    Sabella P; Bottoni F; Staurenghi G
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):599-601. PubMed ID: 19997743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsalva-like retinopathy following hyperopic laser in situ keratomileusis.
    Moshfeghi AA; Harrison SA; Reinstein DZ; Ferrone PJ
    Ophthalmic Surg Lasers Imaging; 2006; 37(6):486-8. PubMed ID: 17152544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal Imaging in Dengue-Fever-Associated Maculopathy.
    Akanda M; Gangaputra S; Kodati S; Melamud A; Sen HN
    Ocul Immunol Inflamm; 2018; 26(5):671-676. PubMed ID: 28980843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A spectral-domain optical coherence tomography description of ND: YAG laser hyaloidotomy in premacular subhyaloid hemorrhage.
    Pichi F; Ciardella AP; Torrazza C; Morara M; Scano G; Mattana G; Nucci P
    Retina; 2012 Apr; 32(4):861-2. PubMed ID: 22298015
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term results of Nd:YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy.
    Durukan AH; Kerimoglu H; Erdurman C; Demirel A; Karagul S
    Eye (Lond); 2008 Feb; 22(2):214-8. PubMed ID: 16946748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retinal arterial macroaneurysm complicated by premacular hemorrhage: treatment by YAG laser disruption].
    Dahreddine M; Eldirani H; Mutsinzi E; Hirsch A
    J Fr Ophtalmol; 2011 Feb; 34(2):131.e1-5. PubMed ID: 21131097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Valsalva retinopathy: Role of SD-OCT and Nd:YAG Laser].
    Fortunati M; Mélard JL
    J Fr Ophtalmol; 2017 Jun; 40(6):e215-e217. PubMed ID: 28583696
    [No Abstract]   [Full Text] [Related]  

  • 16. Bilateral and multiple sub-internal limiting membrane hemorrhages in a familial retinal arteriolar tortuosity patient by Valsalva-like mechanism: an observational case report.
    Chen T; Zheng H; Wang Y; Hu J; Chen C
    BMC Ophthalmol; 2020 Apr; 20(1):151. PubMed ID: 32293357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Valsalva retinopathy treated by Nd:YAG laser].
    Matonti F; Nadeau S; Denis D
    J Fr Ophtalmol; 2013 Jan; 36(1):92. PubMed ID: 23073398
    [No Abstract]   [Full Text] [Related]  

  • 18. Nd:YAG laser treatment for Valsalva premacular hemorrhages: 6 month follow up : alternative management options for preretinal premacular hemorrhages in Valsalva retinopathy.
    Khan MT; Saeed MU; Shehzad MS; Qazi ZA
    Int Ophthalmol; 2008 Oct; 28(5):325-7. PubMed ID: 17891339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nd:YAG laser treatment for Valsalva premacular hemorrhage.
    Zhang P; Wang H; Zhang F; Hu D; Wang Y
    Eye Sci; 2013 Dec; 28(4):208-10. PubMed ID: 24961095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valsalva retinopathy associated with the choking game.
    Ho LY; Abdelghani WM
    Semin Ophthalmol; 2007; 22(2):63-5. PubMed ID: 17564922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.